Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation
Preterm birth, defined as any birth before 37 weeks of completed gestation, poses adverse health risks to both mothers and infants. Despite preterm birth being associated with several risk factors, its relationship to maternal metabolism remains unclear, especially in first-time mothers. Aims of the...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/16/5/595 |
_version_ | 1797264116241399808 |
---|---|
author | Ying-Chieh Han Katarina Laketic Kylie K. Hornaday Donna M. Slater Chunlong Mu Suzanne C. Tough Jane Shearer |
author_facet | Ying-Chieh Han Katarina Laketic Kylie K. Hornaday Donna M. Slater Chunlong Mu Suzanne C. Tough Jane Shearer |
author_sort | Ying-Chieh Han |
collection | DOAJ |
description | Preterm birth, defined as any birth before 37 weeks of completed gestation, poses adverse health risks to both mothers and infants. Despite preterm birth being associated with several risk factors, its relationship to maternal metabolism remains unclear, especially in first-time mothers. Aims of the present study were to identify maternal metabolic disruptions associated with preterm birth and to evaluate their predictive potentials. Blood was collected, and the serum harvested from the mothers of 24 preterm and 42 term births at 28–32 weeks gestation (onset of the 3rd trimester). Serum samples were assayed by untargeted metabolomic analyses via liquid chromatography/mass spectrometry (QTOF-LC/MS). Metabolites were annotated by inputting the observed mass-to-charge ratio into the Human Metabolome Database (HMDB). Analysis of 181 identified metabolites by PLS-DA modeling using SIMCA (v17) showed reasonable separation between the two groups (CV-ANOVA, <i>p</i> = 0.02). Further statistical analysis revealed lower serum levels of various acyl carnitines and amino acid metabolites in preterm mothers. Butenylcarnitine (C4:1), a short-chain acylcarnitine, was found to be the most predictive of preterm birth (AUROC = 0.73, [CI] 0.60–0.86). These observations, in conjuncture with past literature, reveal disruptions in fatty acid oxidation and energy metabolism in preterm primigravida. While these findings require validation, they reflect altered metabolic pathways that may be predictive of preterm delivery in primigravida. |
first_indexed | 2024-04-25T00:23:47Z |
format | Article |
id | doaj.art-ced151e34e524cf68bc47f51514691e1 |
institution | Directory Open Access Journal |
issn | 2072-6643 |
language | English |
last_indexed | 2024-04-25T00:23:47Z |
publishDate | 2024-02-01 |
publisher | MDPI AG |
record_format | Article |
series | Nutrients |
spelling | doaj.art-ced151e34e524cf68bc47f51514691e12024-03-12T16:51:53ZengMDPI AGNutrients2072-66432024-02-0116559510.3390/nu16050595Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary InvestigationYing-Chieh Han0Katarina Laketic1Kylie K. Hornaday2Donna M. Slater3Chunlong Mu4Suzanne C. Tough5Jane Shearer6Department of Biomedical Engineering, Faculty of Engineering, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Biomedical Engineering, Faculty of Engineering, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaAlberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaAlberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Biomedical Engineering, Faculty of Engineering, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaPreterm birth, defined as any birth before 37 weeks of completed gestation, poses adverse health risks to both mothers and infants. Despite preterm birth being associated with several risk factors, its relationship to maternal metabolism remains unclear, especially in first-time mothers. Aims of the present study were to identify maternal metabolic disruptions associated with preterm birth and to evaluate their predictive potentials. Blood was collected, and the serum harvested from the mothers of 24 preterm and 42 term births at 28–32 weeks gestation (onset of the 3rd trimester). Serum samples were assayed by untargeted metabolomic analyses via liquid chromatography/mass spectrometry (QTOF-LC/MS). Metabolites were annotated by inputting the observed mass-to-charge ratio into the Human Metabolome Database (HMDB). Analysis of 181 identified metabolites by PLS-DA modeling using SIMCA (v17) showed reasonable separation between the two groups (CV-ANOVA, <i>p</i> = 0.02). Further statistical analysis revealed lower serum levels of various acyl carnitines and amino acid metabolites in preterm mothers. Butenylcarnitine (C4:1), a short-chain acylcarnitine, was found to be the most predictive of preterm birth (AUROC = 0.73, [CI] 0.60–0.86). These observations, in conjuncture with past literature, reveal disruptions in fatty acid oxidation and energy metabolism in preterm primigravida. While these findings require validation, they reflect altered metabolic pathways that may be predictive of preterm delivery in primigravida.https://www.mdpi.com/2072-6643/16/5/595pregnancymetabolismprimigravidascreeningmetabolomicsmass spectrometry |
spellingShingle | Ying-Chieh Han Katarina Laketic Kylie K. Hornaday Donna M. Slater Chunlong Mu Suzanne C. Tough Jane Shearer Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation Nutrients pregnancy metabolism primigravida screening metabolomics mass spectrometry |
title | Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation |
title_full | Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation |
title_fullStr | Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation |
title_full_unstemmed | Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation |
title_short | Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation |
title_sort | maternal acylcarnitine disruption as a potential predictor of preterm birth in primigravida a preliminary investigation |
topic | pregnancy metabolism primigravida screening metabolomics mass spectrometry |
url | https://www.mdpi.com/2072-6643/16/5/595 |
work_keys_str_mv | AT yingchiehhan maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation AT katarinalaketic maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation AT kyliekhornaday maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation AT donnamslater maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation AT chunlongmu maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation AT suzannectough maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation AT janeshearer maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation |